In addition, IGF2BP2 serves as a reader of RNA m6A (N6 methyladenosine) modification and is implicated in the localization, stabilization, and trafficking of target mRNAs and microRNA biogenesis by recognizing and interacting with m6A methylation, thereby functioning as a tumor promoter in many malignancies [25, 26, 27]. This evidence concerns the gene IGF2BP2 and neoplasm.